Advances in the treatment of polymyalgia rheumatica and giant cell arteritis

被引:0
|
作者
Lindsay Lally
Robert Spiera
机构
[1] Hospital for Special Surgery,
[2] Weill Medical College of Cornell University,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Research published in 2023 has demonstrated the efficacy of sarilumab for IL-6 blockade in polymyalgia rheumatica and of secukinumab for IL-17 blockade in giant cell arteritis (GCA). Furthermore, preliminary results with human monocyte-derived suppressive cells suggest the potential of cellular therapeutics for the treatment of GCA.
引用
收藏
页码:77 / 78
页数:1
相关论文
共 50 条